You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 25 Apr 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Revision Summary:

Regimen Monograph: Changed imatinib to ODB general benefit

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Changed imatinib to ODB General Benefit

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Sarcoma, 
Soft Tissue
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Changed imatinib to ODB general benefit

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Hematologic, 
Leukemia - Chronic Myeloid (CML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Supplementary Public Funding section

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Changed imatinib to ODB general benefit

Updated
Apr 2024
Regimen
Published Date: 25 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Changed imatinib to ODB general benefit

Updated
Apr 2024
Drug

Published Date: 25 Apr 2024

Revision Summary:
Drug Monograph: Modified Supplementary Public Funding section
Updated
Apr 2024
Regimen
Published Date: 23 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2024
Regimen
Published Date: 23 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2024
Regimen
Published Date: 23 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2024
Regimen
Published Date: 23 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2024
Regimen
Published Date: 23 Apr 2024
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Apr 2024

Pages